Availability of Medicines at JAKs

1. At a Glance

• Jan Aushadhi Kendras (JAKs) are dedicated retail outlets selling generic medicines at 50–80% lower prices than branded equivalents, under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) [S1].
• Directly tests health governance, affordable healthcare access, and Centre-driven welfare delivery — recurring UPSC theme under GS-II (Governance/Welfare Schemes) and GS-III (Health infrastructure).
• Implemented by the Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers — a frequently confused nodal ministry (not Ministry of Health) [S1].
• Scale and targets (20,149 JAKs; 25,000 by March 2027) make it a live, number-heavy Prelims topic [S1][S2].

2. Why in the News

• PIB press release dated 24 July 2026 stated that 20,149 JAKs have been opened nationally till 30.06.2026, with a district/constituency-specific breakup for Tamil Nadu's Kallakurichi Lok Sabha Constituency (74 JAKs: 62 in Salem, 12 in Kallakurichi district), likely in response to a Parliament (Lok Sabha) question [S1].
• Follows an earlier PIB release citing 16,912 JAKs as of 30.06.2025, showing a steep expansion within a year [S2].
• Comes on the heels of Janaushadhi Saptah 2026 and the 8th Janaushadhi Diwas observed on 7 March 2026, and news of over 100 crore Suvidha sanitary pads sold as of 31 January 2026 [S3][S4].

3. Background & Evolution

• PMBJP launched in 2008 as "Jan Aushadhi Campaign" by the Department of Pharmaceuticals; relaunched/rebranded as Pradhan Mantri Bhartiya Janaushadhi Pariyojana in 2015-16 with renewed thrust.
• Implementing agency: Pharma & Medical Bureau of India (PMBI) (formerly Bureau of Pharma PSUs of India, BPPI) — a society under the Department of Pharmaceuticals.
• Milestones: Achieved ₹1,000 crore sales target in FY 2023-24 [S from earlier search — Wikipedia/PIB]; 18,646 JAKs by 28.02.2026 [S3]; 20,149 JAKs by 30.06.2026 [S1]; target 25,000 JAKs by March 2027 [S1][S2].
• Cumulative budgetary utilisation of ₹492.73 crore over the three years ending 2025-26 [S1].

4. Core Static Facts

5. Multi-Dimensional Analysis

Economic - Reduces out-of-pocket health expenditure (OOPE), a major driver of poverty in India (linked to NSSO/NITI Aayog health expenditure data). - Creates entrepreneurship/retail opportunities — kendras run by individuals, NGOs, trusts, with government incentive support.

Social - Improves affordable healthcare access for rural and semi-urban populations, cutting across income groups. - Suvidha sanitary pads initiative addresses menstrual health equity for low-income women [S4].

Administrative - Rapid, verifiable expansion trackable via constituency-level PIB data (as shown for Kallakurichi), reflecting outcome-based governance and Parliament accountability [S1]. - Implementation via a Central society (PMBI) with state-level coordination — a Centre-State delivery model.

Governance/Ethical - Transparency demonstrated through granular district/constituency-wise disclosure in response to Parliamentary questions [S1]. - Risk of "outlet count" as vanity metric without ensuring last-mile drug availability/stock consistency at each kendra.

Scientific/Regulatory - Quality assurance architecture (WHO-GMP sourcing + NABL/GLP testing) is a key safeguard against generic-medicine quality skepticism [S1].

6. Recent Developments (last 12-18 months)

• 28.02.2026: 18,646 JAKs operational nationwide [S3].
• 07.03.2026: 8th Janaushadhi Diwas observed, part of Janaushadhi Saptah 2026 outreach campaign [S3].
• 31.01.2026: Over 100 crore Suvidha sanitary pads sold cumulatively [S4].
• 30.06.2026 (reported 24.07.2026): 20,149 JAKs nationally; 1,631 in Tamil Nadu; 74 in Kallakurichi LS constituency [S1].
• Compare: 30.06.2025 figure was 16,912 JAKs — roughly 3,237 new kendras added in one year [S2].

7. Prelims Hooks

• PMBJP is administered by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers — NOT Ministry of Health [S1].
• As of 30.06.2026, 20,149 JAKs operational across India [S1].
• Government target: 25,000 JAKs by March 2027 [S1][S2].
• Tamil Nadu has 1,631 JAKs [S1].
• Kallakurichi Lok Sabha Constituency has 74 JAKs — 62 in Salem district, 12 in Kallakurichi district [S1].
• PMBJP product basket: 2,110 medicines + 315 surgicals/consumables/devices [S1].
• Janaushadhi medicines are 50–80% cheaper than branded equivalents [S1].
• Quality control requires WHO-GMP certified manufacturing and 100% batch pre-testing at NABL-accredited labs [S1].
• 8th Janaushadhi Diwas was observed on 7 March 2026 [S3].
• Over 100 crore Suvidha sanitary pads sold under PMBJP as of 31 January 2026 [S4].
• Implementing agency for PMBJP: Pharma & Medical Bureau of India (PMBI).
• As of 30.06.2025, JAKs stood at 16,912 — a year-on-year jump to 20,149 by 30.06.2026 [S2].

8. Mains Relevance

• GS-II: Government policies and interventions for development in health sector; issues relating to health.
• GS-III: Inclusive growth; issues related to affordability/access in social infrastructure (health).
• Possible question stems: 1. "Discuss how schemes like Pradhan Mantri Bhartiya Janaushadhi Pariyojana address the problem of out-of-pocket health expenditure in India. What administrative challenges persist in scaling such schemes?" 2. "Affordable access to quality generic medicines is central to Universal Health Coverage in India. Examine the design and implementation of PMBJP in this context." 3. "Critically evaluate whether expansion in the number of Jan Aushadhi Kendras translates into actual improvement in medicine accessibility for the poor."

9. Related Topics to Study Next

• Ayushman Bharat / PM-JAY — complementary health financing scheme; compare delivery models.
• National Health Policy 2017 — policy backdrop for affordable healthcare goals.
• Out-of-Pocket Expenditure (OOPE) in India — statistical/economic context for why PMBJP matters.
• Generic vs. Branded medicines regulation — drug pricing, NPPA, DPCO 2013.
• National Pharmaceutical Pricing Authority (NPPA) — regulatory body capping drug prices.
• Menstrual Hygiene Schemes — link via Suvidha sanitary pads initiative.
• Make in India / Pharma PLI Scheme — domestic manufacturing linkage to generic drug supply chain.
• Universal Health Coverage (UHC) & SDG-3 — global health equity framing.

10. Common Errors / Trap Areas

• Confusing nodal ministry: PMBJP falls under Ministry of Chemicals and Fertilizers, not Ministry of Health & Family Welfare.
• Mixing up PMBJP (generic medicine outlets) with PM-JAY/Ayushman Bharat (health insurance) — different schemes, different objectives.
• Misremembering launch year — original Jan Aushadhi Campaign began 2008; PMBJP branding/expansion began 2015-16.
• Treating "JAK count" figures as static — these numbers change with each reporting cycle (till 30.06.2025: 16,912; till 28.02.2026: 18,646; till 30.06.2026: 20,149) — always note the "as on" date [S1][S2][S3].
• Confusing implementing agency PMBI (Pharma & Medical Bureau of India) with other pharma PSUs.

11. Sources

• [S1] Availability of Medicines at JAKs — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2288771 — (tier: 1)
• [S2] Under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme, a total of 16,912 Jan Aushadhi Kendras have been opened till 30.6.2025 — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2149782&reg=48&lang=2 — (tier: 1)
• [S3] Affordable Medicines at Janaushadhi Ensure Quality (Janaushadhi Saptah 2026 doc) — https://static.pib.gov.in/WriteReadData/specificdocs/documents/2026/mar/doc202635810801.pdf — (tier: 1)
• [S4] Janaushadhi Product Basket for Every Healthcare Need — https://static.pib.gov.in/WriteReadData/specificdocs/documents/2026/mar/doc202634810501.pdf — (tier: 1)